ENTR1

Across TCGA pan-cancer cohorts, ENTR1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated ENTR1 data layer compared with 25 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher ENTR1 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated ENTR1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and UCEC show a favorable association.

CCRCC, LUAD, and GBM are the cancer types where ENTR1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Tertile	All	1.000	0.574	.007	19	view →
LUAD	OS	Tertile	All	0.780	1.000	.023	11	view →
GBM	DFS	Tertile	All	0.611	0.804	.018	4	view →
UCEC	OS	Quartile	All	1.000	0.866	.026	4	view →
LSCC	OS	Median	All	0.773	1.000	.029	2	view →
HNSC	DFS	Median	IV	0.920	1.000	.042	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

ENTR1–CCRCC (OS)

Open the CCRCC breakdown →